Roberto Iacone
Chief Executive Officer at Alentis Therapeutics AG
Roberto Iacone active positions
| Companies | Position | Start | End |
|---|---|---|---|
Alentis Therapeutics AG
 Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Director/Board Member | 2020-07-28 | - |
| Chief Executive Officer | 2020-07-28 | - | |
Pureos Partners AG
 Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland. | Private Equity Investor | - | - |
Career history of Roberto Iacone
Former positions of Roberto Iacone
| Companies | Position | Start | End |
|---|---|---|---|
| Ridgeline Therapeutics | Founder | - | - |
Bright Peak Therapeutics AG
 Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Head-Fixed Income Invts | - | - |
Training of Roberto Iacone
| Università degli Studi di Napoli Federico II | Doctorate Degree |
Statistics
International
| Switzerland | 4 |
| United States | 2 |
| Italy | 2 |
Operational
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Head-Fixed Income Invts | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
Alentis Therapeutics AG
Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Health Technology |
Bright Peak Therapeutics AG
Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Health Technology |
| Ridgeline Therapeutics | |
Pureos Partners AG
Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland. | Finance |
- Stock Market
- Insiders
- Roberto Iacone
- Experience
